{"context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "entities": {"mentions": [{"start": 0, "end": 7, "username": "sacjai", "id": "1360077600"}, {"start": 8, "end": 15, "username": "Forbes", "id": "91478624"}], "hashtags": [{"start": 76, "end": 87, "tag": "healthcare"}, {"start": 119, "end": 131, "tag": "innovations"}, {"start": 172, "end": 180, "tag": "COVID19"}]}, "in_reply_to_user_id": "1360077600", "possibly_sensitive": false, "conversation_id": "1259651525665685504", "text": "@sacjai @Forbes Thank you for this insightful piece. My question is how can #healthcare systems invest in new tech and #innovations if they don't have the cash during this #COVID19 crisis? Their operating margins are gone and they are bleeding cash! Unless the solution would have x10 ROI.", "author_id": "457697029", "referenced_tweets": [{"type": "replied_to", "id": "1259651525665685504"}], "source": "Twitter Web App", "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "created_at": "2020-05-11T17:06:52.000Z", "lang": "en", "reply_settings": "everyone", "id": "1259892742882299904"}